These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 4602133)
41. A double-blind study of Trasylol in the treatment of pancreatitis. Bachrach WH; Schild PD Ann N Y Acad Sci; 1968 Jun; 146(2):580-92. PubMed ID: 4891419 [No Abstract] [Full Text] [Related]
42. [Effectiveness of the use of trasylol in the complex therapy of patients with acute and chronic recurrent pancreatitis]. Asauliuk IK Vrach Delo; 1967 Oct; 10():14-6. PubMed ID: 5306817 [No Abstract] [Full Text] [Related]
43. [Acute pancreatitis: conservative treatment with or without the proteinase inhibitor trasylol?]. Scheibe O; Wäller E Med Welt; 1969 Feb; 8():411-4. PubMed ID: 5305630 [No Abstract] [Full Text] [Related]
44. [Treatment of acute pancreatitis and its complications with Trasylol]. Petrow BA; Beljajew AA Zentralbl Chir; 1966 Feb; 91(8):257-60. PubMed ID: 5299613 [No Abstract] [Full Text] [Related]
46. [201 cases of pancreatitis treated with Trasylol]. Asp K; Salmenkivi K Langenbecks Arch Chir; 1969; 325():351-2. PubMed ID: 5309038 [No Abstract] [Full Text] [Related]
47. [On the prognosis of acute pancreatitis]. Moussong S Wien Med Wochenschr; 1968 Apr; 118(17):375-7. PubMed ID: 5303895 [No Abstract] [Full Text] [Related]
48. [Controlled therapeutic trial of aprotinin and glucagon in acute pancreatitis (author's transl)]. Gauthier A; Gillet M; Di Costanzo J; Camelot G; Maurin P; Sarles H Gastroenterol Clin Biol; 1978 Oct; 2(10):777-84. PubMed ID: 365662 [No Abstract] [Full Text] [Related]
50. [On the treatment of pancreatitis and cholecystopancreatitis with trasylol]. Mavrodi VM Vestn Khir Im I I Grek; 1968 May; 100(5):41-3. PubMed ID: 5301803 [No Abstract] [Full Text] [Related]
52. Aprotinin in severe acute pancreatitis. Smith M; Kocher HM; Hunt BJ Int J Clin Pract; 2010 Jan; 64(1):84-92. PubMed ID: 19178597 [TBL] [Abstract][Full Text] [Related]
53. [On the efficacity of trasylol in acute pancreatitis]. Frankenberg BE; Lashchevker VM Klin Med (Mosk); 1968 Mar; 46(3):69-75. PubMed ID: 4970171 [No Abstract] [Full Text] [Related]
54. [The status of Trasylol in the treatment of acute pancreatitis]. Schönbach G Langenbecks Arch Chir; 1969; 325():306-10. PubMed ID: 5309029 [No Abstract] [Full Text] [Related]
55. Comparative clinical study of FOY and Trasylol in acute pancreatitis. Tanaka N; Tsuchiya R; Ishii K Adv Exp Med Biol; 1979; 120B():367-78. PubMed ID: 229707 [TBL] [Abstract][Full Text] [Related]
56. Pancreatic injury following ERCP. Failure of prophylactic benefit of Trasylol. Brust R; Thomson AB; Wensel RH; Sherbaniuk RW; Costopoulos L Gastrointest Endosc; 1977 Nov; 24(2):77-9. PubMed ID: 338412 [No Abstract] [Full Text] [Related]
57. [Effects of acetazolamide, antienzymes and epsilon-aminocaproic acid in amylasemia, in experimental acute pancreatitis]. Morel CJ; Linares CA Prensa Med Argent; 1966 Jun; 53(25):1357-61. PubMed ID: 5298571 [No Abstract] [Full Text] [Related]
58. Problems in treating pancreatitis with enzyme inhibitors. Creutzfeldt W; Schmidt H Anglo Ger Med Rev; 1966 Dec; 3(2):253-73. PubMed ID: 5300697 [No Abstract] [Full Text] [Related]
59. [Use of a new proteinase inhibitor in acute pancreatitis]. Kronberger L; Musil HE; Höllerl G; Prexl HJ; Eide M Wien Med Wochenschr; 1977 Sep; 127(16):517-21. PubMed ID: 303023 [No Abstract] [Full Text] [Related]